| Class 2 Device Recall CD99 | |
Date Initiated by Firm | March 17, 2015 |
Date Posted | April 27, 2015 |
Recall Status1 |
Terminated 3 on June 15, 2015 |
Recall Number | Z-1535-2015 |
Recall Event ID |
70823 |
Product Classification |
Immunohistochemistry reagents and kits - Product Code NJT
|
Product | CD99
Catalog number PM008 AA;
For In Vitro Diagnostic Use.
Product Usage:
Provides adjunctive diagnostic information following the primary diagnosis of a neoplasm by conventional histopathology methods. |
Code Information |
Catalog number PM008 AA; Lot numbers: 110912, Exp 2015/11; 041913, Expiry 2016/04; 120313, Expiry 2016/12; 110314, Expiry 2017/11. |
Recalling Firm/ Manufacturer |
Biocare Medical, LLC 4040 Pike Ln Concord CA 94520-1227
|
For Additional Information Contact | Scott Huntsman 925-603-8033 |
Manufacturer Reason for Recall | A drop in staining intensity over time has been observed. These lots may not meet their labeled shelf life. |
FDA Determined Cause 2 | Unknown/Undetermined by firm |
Action | Biocare sent a Medical Device Notification letters dated March 17, 2015 to all affected sites. The letters identify the affected product, problem, actions to be taken and the fact that it affects all identified lots shipped between 02/13/13 and / 01/28/15. The letters instructed customers to immediately discontinue further use of the recalled lots, dispose of them according to state and local regulations and complete the response form and returned by April 7, 2015. Credit will be issued upon receipt of the response form. |
Quantity in Commerce | 44: 8 of lot 110912, 15 of lot 041913; 17 of lot 120310 and 4 of lot 110314 |
Distribution | Worldwide Distribution - US nationwide in the states of TX, KS, OK, NJ, LA, GA, NC, SC, VA, and the countries of Spain, Austria, Ecuador, Dominican Republic, Vietnam, Kuwait, Hungary and Israel. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|